Benjamin J. Whalley
University of Reading
H-index: 43
Europe-United Kingdom
Top articles of Benjamin J. Whalley
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Use of cannabinoids in the treatment of a neurodegenerative disease or disorder | 2021/3/18 | ||
Use of cannabidiol preparations in the treatment of temporal lobe epilepsy | 2022/12/1 | ||
Cannabidiol preparations and its uses | 2024/1/9 | ||
Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity | Neuron | Evan C Rosenberg Simon Chamberland Michael Bazelot Erica R Nebet Xiaohan Wang | 2023/4/19 |
Cannabidiol-type cannabinoid compound | 2023/2/28 | ||
Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease | 2023/1/26 | ||
7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy | 2023/10/24 | ||
Use of cannabidiol in the treatment of tuberous sclerosis complex | 2023/9/28 | ||
Use of cannabinoids in the treatment of epilepsy | 2024/4/23 | ||
Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof | 2022/9/15 | ||
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) | 2022/12/8 | ||
Use of cannabinoids in the treatment of comorbidities associated with epilepsy | 2022/7/21 | ||
Anvendelse af et phytocannabinoid eller en kombination af phytocannabinoider i behandling af epilepsi | 2022/9/12 | ||
Cannabidivarin preparations for use as a medicament | 2022/12/8 | ||
Use of cannabidiol in the treatment of dravet syndrome | 2022/6/16 | ||
Yhden fytokannabinoidin tai niiden yhdistelmän käyttö epilepsian hoidossa | 2022/8/31 | ||
(+)-trans tetrahydrocannabinol ((+)-trans-thc) for use as a medicament | 2022/12/1 | ||
Use of cannabidiol in combination with 5-ht2b receptor agonists or amphetamines in the treatment of epilepsy | 2022/8/23 | ||
(-)-cis tetrahydrocannabinol ((-)-cis-thc) for use as a medicament | 2022/12/1 | ||
Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy | 2022/12/15 |
Co-Authors
